146 related articles for article (PubMed ID: 37722463)
1. Clinical features, risk factors, and outcomes of diffuse alveolar hemorrhage in antiphospholipid syndrome: A mixed-method approach combining a multicenter cohort with a systematic literature review.
Figueroa-Parra G; Meade-Aguilar JA; Langenfeld HE; González-Treviño M; Hocaoglu M; Hanson AC; Prokop LJ; Murad MH; Cartin-Ceba R; Specks U; Majithia V; Crowson CS; Duarte-García A
Clin Immunol; 2023 Nov; 256():109775. PubMed ID: 37722463
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus-associated diffuse alveolar hemorrhage: a single-center, matched case-control study in China.
Sun Y; Zhou C; Zhao J; Wang Q; Xu D; Zhang S; Shen M; Hou Y; Tian X; Li M; Zeng X
Lupus; 2020 Jun; 29(7):795-803. PubMed ID: 32321345
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation and outcomes in patients with antiphospholipid syndrome-associated adrenal hemorrhage. A multicenter cohort study and systematic literature review.
Meade-Aguilar JA; Figueroa-Parra G; Yang JX; Langenfeld HE; González-Treviño M; Dogra P; Bancos I; Moynagh MR; Murad MH; Prokop LJ; Hanson AC; Crowson CS; Duarte-García A
Clin Immunol; 2024 Mar; 260():109906. PubMed ID: 38244823
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary involvement in catastrophic antiphospholipid syndrome: A descriptive analysis from the "CAPS Registry".
Ponce A; Rodríguez-Pintó I; Espinosa G; Quintas H; Erkan D; Shoenfeld Y; Cervera R;
Semin Arthritis Rheum; 2023 Dec; 63():152265. PubMed ID: 37857048
[TBL] [Abstract][Full Text] [Related]
5. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome.
Zamora MR; Warner ML; Tuder R; Schwarz MI
Medicine (Baltimore); 1997 May; 76(3):192-202. PubMed ID: 9193454
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics of 37 antiphospholipid syndrome patients complicated by autoimmune hemolytic anemia].
Zhang JT; Qi WT; Zhou YZ; Huang C; Zhao JL; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2023 Feb; 62(2):147-155. PubMed ID: 36740405
[No Abstract] [Full Text] [Related]
7. Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry").
Erton ZB; K Leaf R; de Andrade D; Clarke AE; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Gerosa M; Fortin PR; Lopez-Pedrera C; Atsumi T; Zhang Z; Cohen H; Ramires de Jesús G; Branch DW; Wahl D; Andreoli L; Rodriguez-Almaraz E; Petri M; Barilaro G; Zuo Y; Artim-Esen B; Willis R; Quintana R; Vendramini MB; Barber MW; Bertolaccini ML; Roubey R; Erkan D
Lupus; 2022 Dec; 31(14):1770-1776. PubMed ID: 36206383
[TBL] [Abstract][Full Text] [Related]
8. Diffuse alveolar hemorrhage in childhood-onset systemic lupus erythematosus: a severe disease flare with serious outcome.
Blay G; Rodrigues JC; Ferreira JCO; Leal GN; Gormezano NW; Novak GV; Pereira RMR; Terreri MT; Magalhães CS; Molinari BC; Sakamoto AP; Aikawa NE; Campos LMA; Fernandes TAP; Clemente G; Peracchi OAB; Bugni V; Marini R; Sacchetti SB; Carvalho LM; Fraga MM; Castro TCM; Ramos VC; Bonfá E; Silva CA;
Adv Rheumatol; 2018 Nov; 58(1):39. PubMed ID: 30657099
[TBL] [Abstract][Full Text] [Related]
9. Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival.
Kazzaz NM; Coit P; Lewis EE; McCune WJ; Sawalha AH; Knight JS
Lupus Sci Med; 2015; 2(1):e000117. PubMed ID: 26430514
[TBL] [Abstract][Full Text] [Related]
10. Primary Antiphospholipid Syndrome Associated with Diffuse Alveolar Hemorrhage and Pulmonary Thromboembolism.
Isshiki T; Sugino K; Gocho K; Furuya K; Shimizu H; Sekiya M; Ohata T; Wada T; Isobe K; Sakamoto S; Takai Y; Homma S
Intern Med; 2015; 54(16):2029-33. PubMed ID: 26278297
[TBL] [Abstract][Full Text] [Related]
11. Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study.
Guédon AF; Catano J; Ricard L; Laurent C; de Moreuil C; Urbanski G; Deriaz S; Gerotziafas G; Elalamy I; Audemard A; Chasset F; Alamowitch S; Sellam J; Maillot F; Boffa JJ; Cohen A; Abisror N; Fain O; Mekinian A
Arthritis Res Ther; 2022 Jan; 24(1):33. PubMed ID: 35078523
[TBL] [Abstract][Full Text] [Related]
12. Hemoptysis and a cardiac murmur: is it primary or secondary antiphospholipid syndrome?
Kolitz T; Fruchter O; Sasson L; Geva Y; Moreh-Rahav O; Zandman-Goddard G
Lupus; 2019 Dec; 28(14):1712-1715. PubMed ID: 31718483
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome.
Naranjo L; Stojanovich L; Djokovic A; Andreoli L; Tincani A; Maślińska M; Sciascia S; Infantino M; Garcinuño S; Kostyra-Grabczak K; Manfredi M; Regola F; Stanisavljevic N; Milanovic M; Saponjski J; Roccatello D; Cecchi I; Radin M; Benucci M; Pleguezuelo D; Serrano M; Shoenfeld Y; Serrano A
Front Immunol; 2022; 13():957201. PubMed ID: 36172349
[TBL] [Abstract][Full Text] [Related]
14. Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage.
Cartin-Ceba R; Peikert T; Ashrani A; Keogh K; Wylam ME; Ytterberg S; Specks U
Arthritis Care Res (Hoboken); 2014 Feb; 66(2):301-10. PubMed ID: 23983016
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus.
Kim D; Choi J; Cho SK; Choi CB; Kim TH; Jun JB; Yoo DH; Bae SC; Sung YK
Semin Arthritis Rheum; 2017 Jun; 46(6):782-787. PubMed ID: 27745903
[TBL] [Abstract][Full Text] [Related]
16. Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China.
Zhou Y; Hu C; Qi W; Long Y; Huang C; Wang Q; Tian X; Zhao J; Li M; Zeng X
Lupus Sci Med; 2023 Aug; 10(2):. PubMed ID: 37607781
[TBL] [Abstract][Full Text] [Related]
17. Diffuse Alveolar Hemorrhage in Primary Versus Secondary Antiphospholipid Syndrome.
Sangli SS; Ryu JH; Baqir M
J Clin Rheumatol; 2021 Dec; 27(8):e297-e301. PubMed ID: 32195850
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhage.
Martinez-Martinez MU; Sturbaum AK; Alcocer-Varela J; Merayo-Chalico J; Gómez-Martin D; Gómez-Bañuelos Jde J; Saavedra MÁ; Enciso-Peláez S; Faugier-Fuentes E; Maldonado-Velázquez R; Suárez-Larios LM; Vega-Morales D; Casasola-Vargas JC; Carrillo Pérez DL; Abril A; Butendieck R; Irazoque-Palazuelos F; Abud-Mendoza C
J Rheumatol; 2014 Aug; 41(8):1656-61. PubMed ID: 24986849
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis.
Jiang M; Chen R; Zhao L; Zhang X
Arthritis Res Ther; 2021 Feb; 23(1):57. PubMed ID: 33593433
[TBL] [Abstract][Full Text] [Related]
20. "Possible primary antiphospholipid syndrome" with concurrent diffuse alveolar hemorrhaging and Libman-Sacks endocarditis mimicking catastrophic antiphospholipid syndrome.
Suzuki A; Asazuma N; Kikuchi E; Kawanobe T; Horimoto Y; Yokobari R; Kotake S; Okai T
Intern Med; 2012; 51(7):813-6. PubMed ID: 22466846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
